1. |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024, 74(3): 229-263.
|
2. |
Zhang CD, Takeshima H, Sekine S, et al. Prediction of tissue origin of adenocarcinomas in the esophagogastric junction by DNA methylation. Gastric Cancer, 2022, 25(2): 336-345.
|
3. |
宣哲, 王林俊, 徐泽宽. 食管胃结合部腺癌的外科治疗现状与展望. 中华外科杂志, 2020, 23(10): 1008-1012.Yan Q, Lyu ZJ, Zheng JB, et al. Surgical treatment strategies for Siewert type II adenocarcinoma of the esophagogastric junction. Zhonghua Wei Chang Wai Ke Za Zhi, 2020, 23(10): 1008-1012.
|
4. |
Hajishengallis G, Netea MG, Chavakis T. Trained immunity in chronic inflammatory diseases and cancer. Nat Rev Immunol, 2025, Jan 31.
|
5. |
Ghobadi H, Mohammadshahi J, Javaheri N, et al. Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients. Front Med (Lausanne), 2022, 9: 916453.
|
6. |
Polk N, Budai B, Hitre E, et al. High neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) are markers of longer survival after metastasectomy of patients with liver-only metastasis of rectal cancer. Pathol Oncol Res, 2022, 28: 1610315.
|
7. |
Zhang J, Liu H, Yu H, et al. Development of a novel staging classification for SiewertⅡ adenocarcinoma of the esophagogastric junction after neoadjuvant chemotherapy. World J Gastrointest Oncol, 2024, 16(6): 2541-2554.
|
8. |
Dalmonte G, Valente M, Tartamella F, et al. Minimally invasive Ivor Lewis oesophagectomy with trans-hiatal oesophageal transection and transabdominal specimen extraction for SiewertⅡ oesophagogastric cancer. Ann R Coll Surg Engl, 2022, 104(7): e208-e210.208-210.
|
9. |
Prestigiacomo CJ. The HDE: what is it good for? Absolutely nothing? J Neurointerv Surg, 2012, 4(2): 80-81.
|
10. |
Leng J, Wu F, Zhang L. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, or monocyte-to-lymphocyte ratio in endometrial neoplasms: a systematic review and meta-analysis. Front Oncol, 2022, 12: 734948.
|
11. |
Heshmat-Ghahdarijani K, Sarmadi V, Heidari A, et al. The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review. Front Oncol, 2023, 13: 1228076.
|
12. |
Misiewicz A, Dymicka-Piekarska V. Fashionable, but what is their real clinical usefulness? nlr, lmr, and plr as a promising indicator in colorectal cancer prognosis: a systematic review. J Inflamm Res, 2023, 16: 69-81.16-69.
|
13. |
Matsubara S, Mabuchi S, Takeda Y, et al. Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer. PLoS One, 2021, 16(5): e0248871.
|
14. |
Jiang ZS, Xu M Q, Cong ZZ, et al. Predicting prognosis for patients with ESCC before surgery by SVMs ranking with nomogram analyses. Am J Transl Res, 2022, 14(8): 5870-82.
|
15. |
Kam AE, Masood A. The prognostic role of the neutrophil to lymphocyte ratio at recurrence in esophageal squamous cell carcinoma: challenges and future directions. Ann Surg Oncol, 2021, 28(6): 2939-2940.
|
16. |
Lee BM, Cho Y, Kim JW, et al. Prognostic significance of sarcopenia in advanced biliary tract cancer patients. Front Oncol, 2020, 10: 1581.
|
17. |
安徽医科大学简介. 安徽医科大学学报, 2018, 53(2): 封3.Introduction to Anhui Medical UniversityActa Universitatis Medicinalis Anhui, 2018, 53(2): Cover 3.
|
18. |
Han Y, Zheng S, Chen Y. Prognostic value of lymphocyte to monocyte ratio in patients with esophageal cancer: a systematic review and meta-analysis. Front Oncol, 2024 Nov 26: 14: 1401076.
|
19. |
Xu X, Jing J. Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma. Front Oncol, 2022 Oct 21: 12: 900305.
|
20. |
Modica R, Minotta R, Liccardi A, et al. Evaluation of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and systemic immune-inflammation index (SII) as potential biomarkers in patients with sporadic medullary thyroid cancer (MTC). J Pers Med, 2023, 13(6): 953.
|
21. |
Zhou Y, Guo X, Shen L, et al. Predictive significance of systemic immune-inflammation index in patients with breast cancer: a retrospective cohort study. Onco Targets Ther, 2023, 16: 939-960.
|
22. |
Wen Y, Zhu Y, Zhang C, et al. Chronic inflammation, cancer development and immunotherapy. Front Pharmacol, 2022, 13: 1040163.
|
23. |
Poto R, Cristinziano L, Modestino L, et al. Neutrophil extracellular traps, angiogenesis and cancer. Biomedicines, 2022, 10(2): 431.
|
24. |
Kim NY, Chun DH, Kim SY, et al. Prognostic value of systemic inflammatory indices, NLR, PLR, and MPV, for predicting 1-year survival of patients undergoing cytoreductive surgery with HIPEC. J Clin Med, 2019, 8(5): 589.
|
25. |
Mireștean CC, Stan MC, Iancu RI, et al. The prognostic value of platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and monocyte-lymphocyte ratio in head and neck squamous cell carcinoma (HNSCC)-a retrospective single center study and a literature review. Diagnostics (Basel), 2023, 13(22): 3396.
|
26. |
Chou WC, Jha S, Linhoff MW, et al. The NLR gene family: from discovery to present day. Nat Rev Immunol, 2023, 23(10): 635-654.
|
27. |
Mouchli M, Reddy S, Gerrard M, et al. Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma. " Review article. Ann Hepatol, 2021, 22: 100249.
|
28. |
An S, Eo W, Lee S, et al. Monocyte-to-lymphocyte ratio as a determinant of survival in patients with gastric cancer undergoing gastrectomy: a cohort study. Medicine (Baltimore), 2023, 102(22): e33930.
|
29. |
Mozas P, Rivas-Delgado A, Rivero A, et al. High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era. Leuk Res, 2020, 94: 106371.
|
30. |
Wang J, Li J, Wei S, et al. The ratio of platelets to lymphocytes predicts the prognosis of metastatic colorectal cancer: a review and meta-analysis. Gastroenterol Res Pract, 2021 Nov 2: 2021: 9699499.
|
31. |
Wang C, Jin S, Xu S, et al. High systemic immune-inflammation index (SII) represents an unfavorable prognostic factor for small cell lung cancer treated with etoposide and platinum-based chemotherapy. Lung, 2020, 198(2): 405-414.
|
32. |
Guo W, Cai S, Zhang F, et al. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer. Thorac Cancer, 2019, 10(4): 761-768.
|
33. |
Zhao Y, Bai YP, Li LF. Association between systemic immune-inflammation index and psoriasis, psoriasis comorbidities, and all-cause mortality: a study based on NHANES. Immun Inflamm Dis, 2024, 12(10): e70050.
|
34. |
田界勇, 徐广文, 熊燃, 等. 术前中性粒细胞与淋巴细胞比在食管鳞癌中的预后意义. 中山大学学报(医学科学版), 2021, 42(3): 462-467.
|
35. |
Shang QX, Yang YS, Hu WP, et al. Clinical and prognostic significance of preoperative lymphocyte-monocyte ratio, neutrophil-lymphocyte ratio and neutrophil-monocyte ratio on esophageal squamous cell carcinoma patients. Transl Cancer Res, 2020, 9(6): 3903-3914.
|
36. |
Zhang X, Hu D, Lin X, et al. Prognostic value of an inflammation-related index in 6, 865 chinese patients with postoperative digestive tract cancers: The FIESTA Study. Front Oncol, 2019, 9: 427.
|
37. |
Wang Y, Lyu J, Xiao L, et al. Clinical application value of the systemic-immune-inflammation-index for predicting survival in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy or radiotherapy. Dis Esophagus, 2021, 34(Supplement_1): S631-S632.
|
38. |
Ma H, Liu Y, Ye H, et al. The prognostic value of preoperative laboratory data indicators in patients with esophageal carcinoma: an observational study. Medicine (Baltimore), 2024, 103(24): e38477.
|